156 related articles for article (PubMed ID: 22866121)
1. Increased expression of NFATc1 in giant cell lesions of the jaws, cherubism and brown tumor of hyperparathyroidism.
Duarte AP; Gomes CC; Gomez RS; Amaral FR
Oncol Lett; 2011 May; 2(3):571-573. PubMed ID: 22866121
[TBL] [Abstract][Full Text] [Related]
2. NFATc1 and TNFalpha expression in giant cell lesions of the jaws.
Amaral FR; Brito JA; Perdigão PF; Carvalho VM; de Souza PE; Gomez MV; De Marco L; Gomez RS
J Oral Pathol Med; 2010 Mar; 39(3):269-74. PubMed ID: 20002873
[TBL] [Abstract][Full Text] [Related]
3. Quantitative expression analysis of apoptotic/antiapoptotic genes and association with immunolocalization of BAX and BCL-2 in peripheral and central giant cell lesions of the jaws.
Amaral FR; Bernardes VF; Duarte AP; Pereira NB; Vasconcelos AC; Gomez RS; Gomes CC
Tumour Biol; 2011 Oct; 32(5):997-1003. PubMed ID: 21706237
[TBL] [Abstract][Full Text] [Related]
4. So-called hybrid central odontogenic fibroma/central giant cell lesion of the jaws. A report on seven additional cases, including an example in a patient with cherubism, and hypotheses on the pathogenesis.
Tosios KI; Gopalakrishnan R; Koutlas IG
Head Neck Pathol; 2008 Dec; 2(4):333-8. PubMed ID: 20614305
[TBL] [Abstract][Full Text] [Related]
5. WWOX expression in giant cell lesions of the jaws.
Amaral FR; Diniz MG; Bernardes VF; Souza PE; Gomez RS; Gomes CC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):210-3. PubMed ID: 23849374
[TBL] [Abstract][Full Text] [Related]
6. FASN expression, angiogenesis and lymphangiogenesis in central and peripheral giant cell lesions.
Falci SG; Mesquita AT; Andrade BA; Miranda JL; Leon JE; Almeida OP; Santos CR
J Appl Oral Sci; 2014 Apr; 22(2):131-7. PubMed ID: 24676584
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of p53, PCNA, Ki-67, MDM2 and AgNOR in oral peripheral and central giant cell lesions.
Souza PE; Mesquita RA; Gomez RS
Oral Dis; 2000 Jan; 6(1):35-9. PubMed ID: 10673786
[TBL] [Abstract][Full Text] [Related]
8. Immunoexpression of TNF-α and TGF-β in central and peripheral giant cell lesions of the jaws.
de Matos FR; de Moraes M; Nonaka CF; de Souza LB; de Almeida Freitas R
J Oral Pathol Med; 2012 Feb; 41(2):194-9. PubMed ID: 21913991
[TBL] [Abstract][Full Text] [Related]
9. IL-10 and IL-10 receptor overexpression in oral giant cell lesions.
Syrio NF; Faria DR; Gomez RS; Gollob KJ; Dutra WO; Souza PE
Med Oral Patol Oral Cir Bucal; 2011 Jul; 16(4):e488-92. PubMed ID: 21196886
[TBL] [Abstract][Full Text] [Related]
10. Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism.
Kadlub N; Sessiecq Q; Dainese L; Joly A; Lehalle D; Marlin S; Badoual C; Galmiche L; Majoufre-Lefebvre C; Berdal A; Deckert M; Vazquez MP; Descroix V; Coudert AE; Picard A
Hum Pathol; 2016 Dec; 58():62-71. PubMed ID: 27498064
[TBL] [Abstract][Full Text] [Related]
11. Peri-implant peripheral giant cell lesions: report of 13 new cases and comparative histological and immunohistochemical analysis with peripheral and central giant cell lesions.
Morais TM; Soares CD; Aguirre Urizar JM; Alberdi-Navarro J; Almeida OP; Pires FR
Med Oral Patol Oral Cir Bucal; 2019 Nov; 24(6):e739-e745. PubMed ID: 31655833
[TBL] [Abstract][Full Text] [Related]
12. Novel mutations in the SH3BP2 gene associated with sporadic central giant cell lesions and cherubism.
Carvalho VM; Perdigão PF; Amaral FR; de Souza PE; De Marco L; Gomez RS
Oral Dis; 2009 Jan; 15(1):106-10. PubMed ID: 19017279
[TBL] [Abstract][Full Text] [Related]
13. Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation.
Kadlub N; Sessiecq Q; Mandavit M; L'Hermine AC; Badoual C; Galmiche L; Berdal A; Descroix V; Picard A; Coudert AE
Orphanet J Rare Dis; 2018 Sep; 13(1):166. PubMed ID: 30236129
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of argyrophilic nuclear organizer regions in giant cell lesions of jaws.
Sadri D; Hejazi M; Jahanbani J; Forouzandeh A
J Oral Pathol Med; 2010 May; 39(5):431-4. PubMed ID: 20202088
[TBL] [Abstract][Full Text] [Related]
15. Clonality analysis of giant cell lesions of the jaws.
Amaral FR; Gomes CC; Oliveira CS; Souza PE; Gomez RS
Braz Dent J; 2010; 21(4):361-4. PubMed ID: 20976389
[TBL] [Abstract][Full Text] [Related]
16. Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts.
Liu B; Yu SF; Li TJ
J Oral Pathol Med; 2003 Jul; 32(6):367-75. PubMed ID: 12787044
[TBL] [Abstract][Full Text] [Related]
17. SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism.
Lietman SA; Prescott NL; Hicks DG; Westra WH; Levine MA
Clin Orthop Relat Res; 2007 Jun; 459():22-7. PubMed ID: 17545756
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of RANKL in oral giant cell lesions is predictive of aggressiveness.
Martini G; Capella D; Rivero ERC; Gondak RO
Braz Oral Res; 2018 Oct; 32():e115. PubMed ID: 30379236
[TBL] [Abstract][Full Text] [Related]
19. [Bilateral giant cell central granuloma of the jaws in a Noonan syndrome: About one case with emphasizing on bone giant cell lesions of the jaws].
Sizaret D; Tallegas M; de Pinieux G
Ann Pathol; 2022 Apr; 42(3):259-263. PubMed ID: 35058088
[TBL] [Abstract][Full Text] [Related]
20. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism.
Kadlub N; Vazquez MP; Galmiche L; L'Herminé AC; Dainese L; Ulinski T; Fauroux B; Pavlov I; Badoual C; Marlin S; Deckert M; Leboulanger N; Berdal A; Descroix V; Picard A; Coudert AE
J Bone Miner Res; 2015 May; 30(5):878-85. PubMed ID: 25491283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
